Delivery Order SPE2DB24D2205-SPE2DB25FDZMS
- Not listed
- This federal contract award is for the delivery of LYRICA 100 MG CAPSULE 90S to the Defense Logistics Agency (DLA). The $1,335.44 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024 with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of LYRICA 100 MG CAPSULE 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.45 and an ultimate completion date of November 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of LYRICA 150 MG CAPSULE 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,290.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 10, 2025, with a completion date of February 11, 2025. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Lyrica 100 mg capsules (90 count) to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,550.74, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of LYRICA 75 MG CAPSULE 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,643.11 and has an Ultimate Completion Date of March 1, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between...
- The federal contract award is for the delivery of Lyrica 200 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,645.60 and an ultimate completion date of October 19, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency (DLA) awarded a $12,371.13 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LYRICA 25 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- This federal contract award, valued at $13,500.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYRICA 100 MG CAPSULE 90S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs...
- This federal contract award is for the delivery of Lyrica 300mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 28, 2025 with a ceiling value of $1,918.65. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. This contract is not designated as a set-aside award....
- This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FDZMSDelivery Order
This federal contract award is for the delivery of LYRICA 100 MG CAPSULE 90S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,992.07, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/12/25 |